Acta Pharmacologica Sinica 2007 August; 28 (8): 1231-1235; doi: 10.1111/j.1745-7254.2007.00607.x

 
Original Article
[ Full text ]
 
Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line1
 
Te-jen LAI2,3, Sheng-feng HSU4, Te-mao LI4, Horng-chaung HSU5, Jaung-geng LIN4, Chin-jung HSU5, Ming-chih CHOU2, Meng-chih LEE2, Shun-fa YANG2, Yi-chin FONG5,6,7

2Institute of Medicine, Chung Shan Medical University, 3Department of Psychiatry, Chung Shan Medical University Hospital, Taiwan, China; 4Graduate Institute of Acupuncture Science, China Medical University, Taiwan, China; 5Department of Orthopaedic Surgery, China Medical University Hospital, Taiwan, China; 6School of Chinese Medicine, China Medical University, Taiwan, China

 

Aim: Chondrosarcoma is a malignant primary bone tumor that responds poorly to both chemotherapy and radiation therapy. The aim of the present study was to investigate the effect of alendronate, a bisphosphonate, on the invasion and migration of human chondrosarcoma cells (JJ012).

 

Methods: JJ012 cells were treated with alendronate of various concentrations up to 100 µmol/L for a specified period, and then gelatin zymography and matrigel invasion assay was performed to study the effects of alendronate on matrix metalloproteinase (MMP)-2 activity and the invasion ability of JJ012 cells, respectively.

 

Results: Our data showed that alendronate exerted a dose- and time-dependent inhibitory effect on the invasion and migration of JJ012 cells. Furthermore, gelatin zymography and RT-PCR showed that alendronate treatment decreased the activity and mRNA levels of MMP-2 in a concentration-dependent manner.


Conclusion:
Our findings suggest that alendronate may reduce MMP-2 secretion at the transcriptional and translational levels, and inhibit the invasion of chondrosarcoma cell. Therefore, alendronate may be a potential candidate for the systemic therapy of chondro-sarcomas, as well as other malignant diseases.

 

Keywords: alendronate; bisphosphonate; chondrosarcoma; matrix metalloproteinase-2; invasion; migration

 
1 This study was supported by grants from China Medical University (No CMU-93-CM-15 and CMU-94-015) and China Medical University Hospital (No DMR-94-036 and DMR-95-067).

7 Correspondence to Dr Yi-chin FONG.
Phn 88-64-2205-2121, ext 1903.
Fax 88-64-2245-2610.
E-mail yichin.fong@msa.hinet.net; s010002@csmu.edu.tw
Received 2007-01-01     Accepted 2007-02-13

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn